S. Bryson

587 total citations
15 papers, 482 citations indexed

About

S. Bryson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Virology. According to data from OpenAlex, S. Bryson has authored 15 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Virology. Recurrent topics in S. Bryson's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (5 papers) and HIV Research and Treatment (5 papers). S. Bryson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (5 papers) and HIV Research and Treatment (5 papers). S. Bryson collaborates with scholars based in Canada, United States and Spain. S. Bryson's co-authors include E.F. Pai, Jean‐Philippe Julien, José L. Nieva, Rosemary C. Hynes, John W. Schrader, Christy A. Thomson, Gary R. McLean, A. Louise Creagh, Justin R. Porter and William R. Schief and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and The Journal of Immunology.

In The Last Decade

S. Bryson

15 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Bryson Canada 12 271 160 157 110 93 15 482
Amy Jacobs United States 14 292 1.1× 131 0.8× 286 1.8× 155 1.4× 82 0.9× 29 625
James M. Kovacs United States 16 445 1.6× 140 0.9× 318 2.0× 287 2.6× 84 0.9× 22 914
Erica Boni United States 6 254 0.9× 95 0.6× 94 0.6× 98 0.9× 59 0.6× 10 406
Beatriz Apellániz Spain 15 408 1.5× 73 0.5× 245 1.6× 108 1.0× 61 0.7× 28 582
Roy W. Johnson United States 6 246 0.9× 117 0.7× 126 0.8× 154 1.4× 155 1.7× 8 516
G. Natrajan France 7 398 1.5× 52 0.3× 259 1.6× 95 0.9× 94 1.0× 7 635
Shu‐Fang Cheng Taiwan 14 366 1.4× 58 0.4× 164 1.0× 53 0.5× 163 1.8× 33 536
Gary Frey United States 9 315 1.2× 187 1.2× 455 2.9× 209 1.9× 101 1.1× 9 738
Géraldine Laumond France 14 155 0.6× 59 0.4× 244 1.6× 152 1.4× 72 0.8× 37 455

Countries citing papers authored by S. Bryson

Since Specialization
Citations

This map shows the geographic impact of S. Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bryson more than expected).

Fields of papers citing papers by S. Bryson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bryson. The network helps show where S. Bryson may publish in the future.

Co-authorship network of co-authors of S. Bryson

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bryson. A scholar is included among the top collaborators of S. Bryson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bryson. S. Bryson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mabanglo, Mark, Elisa Leung, Siavash Vahidi, et al.. (2019). ClpP protease activation results from the reorganization of the electrostatic interaction networks at the entrance pores. Communications Biology. 2(1). 410–410. 29 indexed citations
2.
Gasparo, Raoul De, S. Bryson, Marcel Kaiser, et al.. (2018). Biological Evaluation and X‐ray Co‐crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma. ChemMedChem. 13(9). 957–967. 16 indexed citations
3.
Dhagat, Urmi, Timothy R. Hercus, Sophie E. Broughton, et al.. (2018). The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities. mAbs. 10(7). 1–12. 9 indexed citations
4.
Goodreid, Jordan D., John Janetzko, John P. Santa Maria, et al.. (2016). Development and Characterization of Potent Cyclic Acyldepsipeptide Analogues with Increased Antimicrobial Activity. Journal of Medicinal Chemistry. 59(2). 624–646. 46 indexed citations
5.
Bryson, S., Christy A. Thomson, Louise F. Risnes, et al.. (2016). Structures of Preferred Human IgV Genes–Based Protective Antibodies Identify How Conserved Residues Contact Diverse Antigens and Assign Source of Specificity to CDR3 Loop Variation. The Journal of Immunology. 196(11). 4723–4730. 14 indexed citations
6.
Persch, Elke, S. Bryson, Christian Eberle, et al.. (2014). Binding to Large Enzyme Pockets: Small‐Molecule Inhibitors of Trypanothione Reductase. ChemMedChem. 9(8). 1880–1891. 43 indexed citations
7.
Apellániz, Beatriz, S. Bryson, Pablo Carravilla, et al.. (2014). Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 Epitope. Journal of Biological Chemistry. 289(10). 6565–6580. 28 indexed citations
8.
Azoitei, Mihai L., Jean‐Philippe Julien, S. Bryson, et al.. (2011). Computational Design of High-Affinity Epitope Scaffolds by Backbone Grafting of a Linear Epitope. Journal of Molecular Biology. 415(1). 175–192. 80 indexed citations
9.
Bryson, S., Jean‐Philippe Julien, Rosemary C. Hynes, & E.F. Pai. (2009). Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications. Journal of Virology. 83(22). 11862–11875. 47 indexed citations
10.
Bryson, S., Jean‐Philippe Julien, David E. Isenman, et al.. (2008). Crystal Structure of the Complex between the Fab′ Fragment of the Cross-Neutralizing Anti-HIV-1 Antibody 2F5 and the Fab Fragment of Its Anti-idiotypic Antibody 3H6. Journal of Molecular Biology. 382(4). 910–919. 15 indexed citations
11.
Julien, Jean‐Philippe, S. Bryson, José L. Nieva, & E.F. Pai. (2008). Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site. Journal of Molecular Biology. 384(2). 377–392. 70 indexed citations
12.
Thomson, Christy A., S. Bryson, Gary R. McLean, et al.. (2008). Germline V‐genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. The EMBO Journal. 27(19). 2592–2602. 56 indexed citations
13.
McLean, Gary R., Marcela Torres, Michela Noseda, et al.. (2005). A point mutation in the Ch3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity. Molecular Immunology. 42(9). 1111–1119. 4 indexed citations
14.
Yen, Ten‐Yang, Bruce A. Macher, S. Bryson, et al.. (2003). Highly Conserved Cysteines of Mouse Core 2 β1,6-N-Acetylglucosaminyltransferase I Form a Network of Disulfide Bonds and Include a Thiol That Affects Enzyme Activity. Journal of Biological Chemistry. 278(46). 45864–45881. 15 indexed citations
15.
Bryson, S., Rosemary C. Hynes, David E. Isenman, et al.. (2001). Cross-Neutralizing Human Monoclonal Anti-HIV-1 Antibody 2F5: Preparation and Crystallographic Analysis of the Free and Epitope-Complexed Forms of its F ab Fragment. Protein and Peptide Letters. 8(5). 413–418. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026